Skip to main content
. 2024 Feb 27;26:e48168. doi: 10.2196/48168

Table 3.

Subgroup analyses for overall attrition rate in conversational agent (CA)–delivered mental health interventions.

Subgroups Short-term studies (≤8 wk) Long-term studies (>8 wk) 

Interventions, n Attrition rate, % (95% CI) I2 (%) P value Interventions, n Attrition rate, % (95% CI) I2 (%) P value
Risk of bias .21
.22

High risk of bias 8 26.18 (15.69-38.13) 89.6
4 22.31 (17.85-27.10) 0

Low risk of bias 18 14.76 (4.27-29.25) 95.6
11 28.35 (20.25-37.20) 95.4
Funding source .71
.38

Industry funding 9 20.43 (8.78-35.06) 92.4
4 32.36 (18.14-48.46) 97.0

Public funding only 17 16.56 (6.35-29.79) 95.1
11 23.19 (15.92-33.65) 92.1
Duration (wk) .43
.68

0-4 17 15.57 (5.10-29.92) 95.3
N/Aa N/A N/A

5-8 9 23.15 (11.13-37.67) 93.4
N/A N/A N/A

9-12 N/A N/A N/A
11 25.30 (19.35-31.75) 90.3

>13 N/A N/A N/A
4 30.04 (10.75-53.88) 96.1
Study design .65
.19

RCTb 19 19.68 (10.34-30.95) 95.2
14 26.00 (19.33-33.27) 94.3

Pilot RCT 7 12.73 (0-38.45) 91.8   1 N/A N/A  
Type of disorder .80
.32

Depression 6 17.89 (5.44-34.60) 91.5
11 24.03 (17.74-30.93) 91.4

Depression and anxiety 5 7.68 (0-40.93) 97.1
N/A N/A N/A

Mental well-being 9 24.29 (8.37-44.57) 94.2
N/A N/A N/A

Otherc 4 20.02 (10.61-31.36) 81.9
3 33.77 (17.01- 52.90) 94.9
With CBTd .41
.65

Yes 17 21.35 (11.26-33.41) 95.1
12 27.51 (20.16-35.31) 94.5  

No 9 11.64 (0.21-33.29) 93.8
3 22.99 (7.94-42.72) 92  
With mindfulness component .02
.27

Yes 12 30.24 (17.02-45.27) 95.5
11 23.89 (17.67-30.71) 91.5

No 14 8.66 (0.89-21.20) 92.8
4 34.35 (18.00-52.84) 93.8
Personalization .63
.53

No personalization 6 17.04 (5.08-33.33) 84.7
2 38.10 (10.38-70.94) 97.1

Minimal personalization 2 44.57 (2.50-92.50) 96.0
N/A N/A N/A

Substantial personalization 9 21.56 (12.52-32.12) 89.0
12 25.25 (19.16-31.85) 91.3

Major personalization 9 10.98 (0-35.05) 96.5
1 19.51 (8.61-33.23) N/A
CA algorithm .42
.49

Rule based 16 21.53 (11.72-33.12) 93.1
13 25.02 (19.30-31.19) 90.6

AIe enhanced 10 13.25 (1.29-32.79) 96.2
2 37.16 (8.05-72.63) 95
Type of CA .14
.16

No avatar 3 33.36 (15.39-54.24) 94.36
12 29.21 (21.81-37.19) 94.6

ECAf 6 8.03 (1.37-18.04) 59
2 15.35 (5.05-29.63) 80.3

Avatar 13 20.13 (6.67-37.97) 96.4
1 19.51 (8.61-33.23) N/A

Not specified 4 15.15 (1.79-35.93) 86.4
N/A N/A N/A
With rewards component .74
<.001g

Yes 15 16.63 (9.93-27.41) 92.4
1 54.83 (49.60-60.00) 89.9

No 11 20.07 (5.77;-39.39) 96
14 24.68 (19.20-30.59)

Reminder .20
.98

With reminder 14 23.96 (12.19-37.99) 94.8
7 26.42 (14.80-39.96) 95.7

Without reminder 12 11.43 (1.76-26.27) 94.7
8 26.51 (17.85-36.16) 92.1
Delivery channel .02g
<.001g

Web based 4 30.74 (15.26-48.70) 91.5
11 26.96 (20.73-33.66) 90.8

Computer- or laptop computer– or tablet computer–embedded program 6 4.72 (0.06-13.49) 61.5
1 9.33 (3.62-17.12) N/A

Smartphone app 10 14.32 (5.71-25.56) 87.5
1 54.83 (49.60-60.00) N/A

Messenging app based (meaning Slack, Facebook Messenger, or WeChat based) 6 33.27 (10.58-60.80) 96.9
1 19.51 (8.61-33.23) N/A

Not specified N/A N/A N/A
1 22.11 (14.27-31.06) N/A
With blended component .38
.02

Yes 3 19.12 (10.38-29.56) 95.1
6 18.65 (12.86-25.20) 75.4

No 23 9.89 (0.35-26.31) 38.8
9 32.54 (23.01-42.84) 94.9
Enrollment method .15
.12

Remote options only 14 26.63 (15.19-39.82) 95.4
9 30.18 (20.38-40.95) 95.6

With in-person option 10 9.68 (0.15-27.14) 92
6 21.28 (16.69-26.26) 53.7

Not specified 2 5.02 (0-33.08) 88
N/A N/A N/A
Study population .05g 
.41

At risk 11 19.92 (1.53-29.81) 90.1
7 30.10 (17.09-44.93) 96.4

Clinical 4 3.53 (0-13.05) 36
8 23.87 (18.55-29.61) 76.5

General 11 22.05 (6.73-42.30) 96.1
N/A N/A N/A
Session length .61
.34

Defined session length 15 20.26 (9.93-32.79) 94.1
14 27.05 (20.28-34.38) 94.3

User determined 11 15.31 (3.17-33.12) 95.4
1 19.51 (8.61-33.23) N/A
With symptom trackers component .99
.003

Yes 14 17.77 (6.44-32.52) 93.9
6 16.36 (10.32-23.39) 64.1

No 12 18.22 (7.21-32.44) 95.3
9 33.48 (24.91-42.62) 95.4

aN/A: not applicable.

bRCT: randomized controlled trial.

cAnxiety only, panic disorder, height phobia, gambling disorder, substance abuse, attention-deficit/hyperactivity disorder, irritable bowel syndrome, eating disorder, and personality disorder.

dCBT: cognitive behavioral therapy.

eAI: artificial intelligence.

fECA: embodied CA.

gSubgroup analyses were not significant after dropping subgroups with <5 studies.